-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$18.6797.36% Upside
IGM Biosciences, Inc. Frequently Asked Questions
-
What analysts cover IGM Biosciences, Inc.?
IGM Biosciences, Inc. has been rated by research analysts at BMO Capital, RBC Capital, Stifel Nicolaus, Truist Financial, Wedbush, Morgan Stanley in the past 90 days.